刘婷婷,蒋翠婷,吕 静,徐禄香

总结：1例行自体造血干细胞移植联合CAR-T治疗淋巴瘤合并新冠感染患者的护理经验。护理要点：做好细胞因子释放综合征的观察与护理，密切监测体温变化，做好发热的评估与鉴别，落实高热护理措施；严密监测缺氧程度，维持及促进呼吸功能；关注疲乏程度，重视功能锻炼；做好营养筛查，制订营养支持计划；加强病情观察，及早识别神经毒性症状；关注骨髓抑制程度，预防严重感染与出血；严格落实防控措施，制订移植病房新冠管理策略。经多学科团队的协作诊治与精细护理，患者恢复良好，于回输后第30d顺利出院。

淋巴瘤；造血干细胞移植；CAR-T；新冠感染；护理

[1] Skulimowska I,Sosniak J,Gonka M,Szade A,Jozkowicz A,Szade K.The biology of hematopoietic stem cells and its clinical implications.Febs j.Dec 2022;289(24):7740-7759. [2] Passweg JR,Baldomero H,Chabannon C,et al.Hematopoietic cell transplantation and cellular therapy survey of the EBMT:monitoring of activities and trends over 30 years.Bone Marrow Transplant. Jul 2021;56(7):1651-1664. [3] Xu LP,Lu PH,Wu DP,et al.Hematopoietic stem cell transplantation activity in China 2019:a report from the Chinese Blood and Marrow Transplantation Registry Group.Bone Marrow Transplant.Dec 2021;56(12):2940-2947. [4] Snowden JA,Sánchez-Ortega I,Corbacioglu S,et al.Indications for haematopoietic cell transplantation for haematological diseases,solid tumours and immune disorders:current practice in Europe,2022.Bone Marrow Transplant.Aug 2022;57(8):1217-1239. [5] Annesley CE,Summers C,Ceppi F,Gardner RA.The Evolution and Future of CAR T Cells for B-Cell Acute Lymphoblastic Leukemia.Clin Pharmacol Ther.Apr 2018;103(4):591-598. [6] 李珊,梁书洁,赖沛龙,杜欣.2023年CAR-T细胞在血液恶性肿瘤治疗的研究进展.循证医学.2023;23(06):328-331+370. [7] 《关于对新型冠状病毒感染实施“乙类乙管”的总体方案》解读问答.中国新闻发布(实务版).2023(01):21-24. [8] Lee DW,Santomasso BD,Locke FL,et al.ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells.Biol Blood Marrow Transplant.Apr 2019;25(4):625-638. [9] Santomasso B,Bachier C,Westin J,Rezvani K,Shpall EJ.The Other Side of CAR T-Cell Therapy:Cytokine Release Syndrome,Neurologic Toxicity,and Financial Burden.Am Soc Clin Oncol Educ Book.Jan 2019;39:433-444. [10] Los-Arcos I,Iacoboni G,Aguilar-Guisado M,et al.Recommendations for screening,monitoring,prevention,and prophylaxis of infections in adult and pediatric patients receiving CAR T-cell therapy:a position paper.Infection.Apr 2021;49(2):215-231. [11] Davila ML,Riviere I,Wang X,et al.Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia.Sci Transl Med.Feb 19 2014;6(224):224ra225. [12] Liu S,Deng B,Yin Z,et al.Corticosteroids do not influence the efficacy and kinetics of CAR-T cells for B-cell acute lymphoblastic leukemia.Blood Cancer J.Feb 6 2020;10(2):15. [13] Munoz AM,Urak R,Taus E,et al.Dexamethasone potentiates chimeric antigen receptor T cell persistence and function by enhancing IL-7Rαexpression.Mol Ther.Feb 7 2024;32(2):527-539. [14] 许苗,代兴斌,朱学军.CAR-T免疫疗法所致细胞因子释放和神经毒性综合征的诊疗研究进展.中国肿瘤生物治疗杂志.2021;28(06):629-635. [15] Chen P,Tang Y,He W,et al.Potential Pathophysiological Mechanisms Underlying Multiple Organ Dysfunction in Cytokine Release Syndrome.Mediators Inflamm.2022;2022:7137900. [16] Gorordo-Delsol LA,Mandolado-Beltrán I,Rodríguez-Peredo A,Garduño-López J,Gómez-Alaniz KI.Prolonged and Uninterrupted Prone Position in Acute Respiratory Distress Syndrome.Crit Care Med.Aug 1 2021;49(8):e809-e810. [17] 郑飞,李杰,邢桃红.呼吸系统疾病清醒俯卧位通气病人真实体验的质性研究.全科护理.2024;22(04):743-746. [18] Ullrich CK,Baker KK,Carpenter PA,et al.Fatigue in Hematopoietic Cell Transplantation Survivors:Correlates,Care Team Communication,and Patient-Identified Mitigation Strategies.Transplant Cell Ther.Mar 2023;29(3):200.e201-200.e208. [19] 陈婧怡,胡荣,王滨滨,李张杰.造血干细胞移植患者疲乏管理的最佳证据总结.中华护理杂志.2023;58(05):609-617. [20] Oken MM,Creech RH,Tormey DC,et al.Toxicity and response criteria of the Eastern Cooperative Oncology Group.Am J Clin Oncol.Dec 1982;5(6):649-655. [21] Abo S,Denehy L,Ritchie D,et al.People With Hematological Malignancies Treated With Bone Marrow Transplantation Have Improved Function,Quality of Life,and Fatigue Following Exercise Intervention:A Systematic Review and Meta-Analysis.Phys Ther.Aug 1 2021;101(8). [22] Duong N,Davis H,Robinson PD,et al.Mind and body practices for fatigue reduction in patients with cancer and hematopoietic stem cell transplant recipients:A systematic review and meta-analysis.Crit Rev Oncol Hematol.Dec 2017;120:210-216. [23] 朱春颖,叶国芬,刘敏慧,夏燕,肖志慧,王波.造血干细胞移植术后患者营养不良影响因素的范围综述.上海护理.2021;21(12):54-58. [24] Liu P,Wang B,Yan X,Cai J,Wang Y.Comprehensive evaluation of nutritional status before and after hematopoietic stem cell transplantation in 170 patients with hematological diseases.Chin J Cancer Res.Dec 2016;28(6):626-633. [25] 谢辰,方云,刘敏杰,张伟伟,曹兰艳,程斯.造血干细胞移植患者饮食与营养教育的证据总结.护理学杂志.2021;36(10):102-106. [26] Muscaritoli M,Arends J,Bachmann P,et al.ESPEN practical guideline:Clinical Nutrition in cancer.Clin Nutr.May 2021;40(5):2898-2913. [27] Fang Y,Liu MJ,Zhang WW,Xie C,Liu ZZ.Nutrition Support Practices of Hematopoietic Stem Cell Transplantation Centers in Mainland China.Curr Med Sci.Aug 2020;40(4):691-698. [28] Atkins L,Steer B,Ray H,Kiss N.Implementing and sustaining an evidence-based nutrition service in a haematology unit for autologous stem cell transplant patients.Support Care Cancer.Mar 2019;27(3):951-958. [29] Grigor EJM,Fergusson D,Kekre N,et al.Risks and Benefits of Chimeric Antigen Receptor T-Cell(CAR-T)Therapy in Cancer:A Systematic Review and Meta-Analysis.Transfus Med Rev.Apr 2019;33(2):98-110. [30] Neelapu SS,Tummala S,Kebriaei P,et al.Chimeric antigen receptor T-cell therapy-assessment and management of toxicities.Nat Rev Clin Oncol.Jan 2018;15(1):47-62. [31] Sheth VS,Gauthier J.Taming the beast:CRS and ICANS after CAR T-cell therapy for ALL.Bone Marrow Transplant.Mar 2021;56(3):552-566. [32] Schubert ML,Schmitt M,Wang L,et al.Side-effect management of chimeric antigen receptor(CAR)T-cell therapy.Ann Oncol.Jan 2021;32(1):34-48. [33] Neelapu SS.Managing the toxicities of CAR T-cell therapy.Hematol Oncol.Jun 2019;37 Suppl 1:48-52. [34] Karschnia P,Jordan JT,Forst DA,et al.Clinical presentation,management,and biomarkers of neurotoxicity after adoptive immunotherapy with CAR T cells.Blood.May 16 2019;133(20):2212-2221. [35] Franco R,Lupi E,Iacomino E,et al.Low-Level Laser Therapy for the Treatment of Oral Mucositis Induced by Hematopoietic Stem Cell Transplantation:A Systematic Review with MetaAnalysis. Medicina(Kaunas).Aug 3 2023;59(8). [36] 刘明红,王海慧,周爱萍,戚嘉乾,王维娟.造血干细胞移植患者移植早期肛周感染的影响因素.中华医院感染学杂志.2021;31(24):3782-3786. [37] Busca A,Salmanton-García J,Corradini P,et al.COVID-19 and CAR T cells:a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP.Blood Adv.Apr 12 2022;6(7):2427-2433. [38] Shahzad M,Chaudhary SG,Zafar MU,et al.Impact of COVID-19 in hematopoietic stem cell transplant recipients:A systematic review and meta-analysis.Transpl Infect Dis.Apr 2022;24(2):e13792. [39] Hu Y,Tan Su Yin E,Yang Y,et al.CAR T-cell treatment during the COVID-19 pandemic:Management strategies and challenges.Curr Res Transl Med.Aug 2020;68(3):111-118.

点击下载PDF